Chuanfang Wu

1.6k total citations
59 papers, 1.3k citations indexed

About

Chuanfang Wu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Chuanfang Wu has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Cancer Research. Recurrent topics in Chuanfang Wu's work include Glycosylation and Glycoproteins Research (8 papers), Autophagy in Disease and Therapy (8 papers) and RNA modifications and cancer (7 papers). Chuanfang Wu is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Autophagy in Disease and Therapy (8 papers) and RNA modifications and cancer (7 papers). Chuanfang Wu collaborates with scholars based in China, Belgium and United States. Chuanfang Wu's co-authors include Jinku Bao, Ling Li, Wenchuan Qi, Zhenhua Li, Jiangshan Dai, Qiao Zhang, Yu Liu, Xu Song, Lan Yang and Yu Luo and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Chuanfang Wu

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanfang Wu China 19 884 499 208 114 109 59 1.3k
Seema Kumari India 16 708 0.8× 309 0.6× 97 0.5× 87 0.8× 131 1.2× 45 1.3k
Qianping Chen China 19 545 0.6× 326 0.7× 258 1.2× 116 1.0× 96 0.9× 54 1.0k
Byoung Heon Kang South Korea 21 1.6k 1.8× 249 0.5× 106 0.5× 166 1.5× 171 1.6× 46 2.0k
Alena Hyršlová Vaculová Czechia 21 784 0.9× 313 0.6× 104 0.5× 121 1.1× 103 0.9× 43 1.2k
Xiaoping Wu China 22 864 1.0× 237 0.5× 98 0.5× 83 0.7× 173 1.6× 81 1.4k
Tianqi Ming China 11 595 0.7× 201 0.4× 118 0.6× 61 0.5× 83 0.8× 16 1.1k
Zhongyi Hu United States 21 1.4k 1.6× 767 1.5× 127 0.6× 97 0.9× 95 0.9× 46 1.8k
Shenglin Zhao China 5 762 0.9× 196 0.4× 70 0.3× 246 2.2× 106 1.0× 13 1.2k

Countries citing papers authored by Chuanfang Wu

Since Specialization
Citations

This map shows the geographic impact of Chuanfang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanfang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanfang Wu more than expected).

Fields of papers citing papers by Chuanfang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanfang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanfang Wu. The network helps show where Chuanfang Wu may publish in the future.

Co-authorship network of co-authors of Chuanfang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanfang Wu. A scholar is included among the top collaborators of Chuanfang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanfang Wu. Chuanfang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanfei, Chao Zhang, Zhiye Ying, et al.. (2025). Psychiatric disorders and following risk of chronic kidney disease: a prospective cohort study from UK Biobank. BMC Psychiatry. 25(1). 109–109. 1 indexed citations
2.
Wang, Yida, Xiaoyu Li, Xin Wang, et al.. (2024). O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells. Redox Biology. 73. 103182–103182. 20 indexed citations
4.
Wang, Xin, et al.. (2023). Identification of glycogene-based prognostic signature and validation of B3GNT7 as a potential biomarker and therapeutic target in breast cancer. Journal of Cancer Research and Clinical Oncology. 149(19). 16957–16969.
5.
Yu, Kang‐Kang, et al.. (2023). G-Quadruplex Structures as a “Switch” Regulate ATF4 Expression in Ferroptotic HepG2 Cells. ACS Chemical Biology. 18(2). 273–284. 4 indexed citations
6.
Xiong, Jian, et al.. (2021). Research Progress of Ferroptosis: A Bibliometrics and Visual Analysis Study. Journal of Healthcare Engineering. 2021. 1–13. 17 indexed citations
7.
Wang, Yuqing, et al.. (2020). A novel mannose-binding lectin from with anti-fungal and anti-tumor activities. Acta Biochimica et Biophysica Sinica. 52(10). 1081–1092. 7 indexed citations
8.
Qi, Wenchuan, Zhenhua Li, Chunlan Yang, et al.. (2020). Inhibitory mechanism of muscone in liver cancer involves the induction of apoptosis and autophagy. Oncology Reports. 43(3). 839–850. 24 indexed citations
9.
Chen, Jinwu, Xiaojie Li, Ling Li, et al.. (2019). Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria. Cell Research. 29(9). 711–724. 31 indexed citations
10.
Bao, Minyue, et al.. (2018). Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach. Journal of Biomolecular Structure and Dynamics. 37(15). 4092–4103. 18 indexed citations
12.
Yang, Lan, et al.. (2018). Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. Nucleic Acids Research. 46(11). 5809–5821. 151 indexed citations
13.
Wang, Haiyang, et al.. (2016). Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 17(7). 1055–1055. 32 indexed citations
14.
Liu, Tao, Lei Wu, Di Wang, et al.. (2016). Role of reactive oxygen species-mediated MAPK and NF-κB activation inpolygonatum cyrtonemalectin-induced apoptosis and autophagy in human lung adenocarcinoma A549 cells. The Journal of Biochemistry. 160(6). 315–324. 55 indexed citations
15.
Li, Jing, Nan Zhou, Kun Luo, et al.. (2014). In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy. International Journal of Molecular Sciences. 15(9). 15994–16011. 53 indexed citations
16.
Zhang, Qing, et al.. (2014). The RNA recognition motif domains of RBM5 are required for RNA binding and cancer cell proliferation inhibition. Biochemical and Biophysical Research Communications. 444(3). 445–450. 13 indexed citations
17.
Zhang, Bin, Wei Qi, Yanan Zhu, et al.. (2014). Conformational study reveals amino acid residues essential for hemagglutinating and anti-proliferative activities of <italic>Clematis montana</italic> lectin. Acta Biochimica et Biophysica Sinica. 46(11). 923–934. 7 indexed citations
18.
Liu, Yu, et al.. (2014). 17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Biochemical and Biophysical Research Communications. 445(2). 388–393. 99 indexed citations
19.
20.
Gong, Meng, Jie An, Hongzhou Lu, et al.. (2004). Effects of Denaturation and Amino Acid Modification on Fluorescence Spectrum and Hemagglutinating Activity of <italic>Hericium erinaceum</italic> Lectin. Acta Biochimica et Biophysica Sinica. 36(5). 343–350. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026